Anna K. Puszko

Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity

Dagmara Tymecka, Anna K. Puszko, Piotr F. J. Lipiński et al. · European Journal of Medicinal Chemistry · 2018 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design, synthesis and in vitro biological evaluation of a small cyclic peptide as inhibitor of vascular endothelial growth factor binding to neuropilin-1

K. Grabowska, Anna K. Puszko, Piotr F. J. Lipiński et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1

K. Grabowska, Anna K. Puszko, Piotr F. J. Lipiński et al. · Bioorganic & Medicinal Chemistry · 2016 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1

Dagmara Tymecka, Piotr F. J. Lipiński, Bartłomiej Fedorczyk et al. · Peptides · 2017 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma

Aurore Dumond, Etienne Brachet, Jérôme Durivault et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17